64Cu-LLP2A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 64Cu-LLP2A, covering 2024-11-12 to 2025-07-31. Get the full timeline:
Most recent: Clinical Trial Update: 64Cu-LLP2A for Imaging Hematologic Malignancies [EARLY_Phase 1]